• SPX
  • 6047.15
  • 0.24 %
  • 14.77
  • DJI
  • 44782
  • -0.29 %
  • -128.6484
  • N225
  • 38513.02
  • 0.8 %
  • 304.9883
  • FTSE
  • 8312.89
  • 0.31 %
  • 25.5898
  • IXIC
  • 19403.947
  • 0.97 %
  • 185.7813
iCAD, Inc. (ICAD) Stock Price, News & Analysis

iCAD, Inc. (ICAD) Stock Price, News & Analysis

Currency in USD Disclaimer

$1.76

$0.03

(1.45%)

Day's range
$1.73
Day's range
$1.84
50-day range
$1.34
Day's range
$2.42
  • Country: US
  • ISIN: US44934S2068
52 wk range
$1.18
Day's range
$2.65


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -6.21
  • Piotroski Score 2.00
  • Grade Buy
  • Symbol (ICAD)
  • Company iCAD, Inc.
  • Price $1.76
  • Changes Percentage (1.45%)
  • Change $0.03
  • Day Low $1.73
  • Day High $1.84
  • Year High $2.65

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment. It also offers ProFound AI, a deep-learning algorithm designed to detect malignant soft-tissue densities and calcifications in digital breast tomosynthesis; ProFound AI Risk, a tool that provides breast cancer risk estimation based on a screening mammogram; and magnetic resonance imaging applications, a tool to detect breast and prostate cancer. In addition, the company offers VeraLook, a solution designed to support the detection of colonic polyps in conjunction with CT Colonography. Further, it provides Xoft Axxent electronic brachytherapy systems for the treatment of early stage breast, non-melanoma skin, and gynecological cancers to university research and community hospitals, cancer care clinics, veterinary facilities, and dermatology offices. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers. It also exports its products in Europe, Taiwan, Canada, China, and internationally. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 02/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Strong Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.20
  • Trailing P/E Ratio -7.55
  • Forward P/E Ratio -7.55
  • P/E Growth -7.55
  • Net Income $-4,847,000

Income Statement

Quarterly

Annual

Latest News of ICAD

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

iCAD, Inc. Frequently Asked Questions

  • What is the iCAD, Inc. stock price today?

    Today's price of iCAD, Inc. is $1.76 — it has increased by +1.45% in the past 24 hours. Watch iCAD, Inc. stock price performance more closely on the chart.

  • Does iCAD, Inc. release reports?

    Yes, you can track iCAD, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the iCAD, Inc. stock forecast?

    Watch the iCAD, Inc. chart and read a more detailed iCAD, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is iCAD, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by iCAD, Inc. stock ticker.

  • How to buy iCAD, Inc. stocks?

    Like other stocks, ICAD shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is iCAD, Inc.'s EBITDA?

    iCAD, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in iCAD, Inc.’s financial statements.

  • What is the iCAD, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -0.2798822035, which equates to approximately -27.99%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in iCAD, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including iCAD, Inc.'s financials relevant news, and technical analysis. iCAD, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for iCAD, Inc. stock currently indicates a “sell” signal. For more insights, review iCAD, Inc.’s technical analysis.

  • A revenue figure for iCAD, Inc. for its last quarter?

    iCAD, Inc. published it's last quarterly revenues at $4.22 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.